UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

Leukemia, 2017-08, Vol.31 (8), p.1788-1797

2017

Link zum Volltext

Verfügbarkeit prüfen

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

Cancer cell, 2019-03, Vol.35 (3), p.473-488.e6

2019

Link zum Volltext

Verfügbarkeit prüfen

CD103 + cDC1 and endogenous CD8 + T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

Nature communications, 2020-12, Vol.11 (1), p.6171-6171, Article 6171

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Leukemia, 2021-02, Vol.35 (2), p.506-521

2021

Link zum Volltext

Verfügbarkeit prüfen

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System

Cell reports (Cambridge), 2018-05, Vol.23 (7), p.2130-2141

2018

Link zum Volltext

Verfügbarkeit prüfen

At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies

Journal of leukocyte biology, 2016-12, Vol.100 (6), p.1255-1264

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of a Prototype Test Rig for Leak Detection in Pipelines

Procedia CIRP, 2019, Vol.80, p.524-529

2019

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte‐colony stimulating factor in COVID‐19: Is it stimulating more than just the bone marrow?

American journal of hematology, 2020-08, Vol.95 (8), p.E210-E213

2020

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection

Clinical infectious diseases, 2022-03, Vol.74 (4), p.567-574

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Blood advances, 2021-03, Vol.5 (5), p.1552-1564

2021

Link zum Volltext

Verfügbarkeit prüfen

Oncologic immunomodulatory agents in patients with cancer and COVID-19

Scientific reports, 2021-03, Vol.11 (1), p.4814-4814, Article 4814

2021

Link zum Volltext

Verfügbarkeit prüfen

CARs of the future

American journal of hematology, 2019-05, Vol.94 (S1), p.S55-S58

2019

Link zum Volltext

Verfügbarkeit prüfen

An interactive approach towards the development of an additive manufacturing technology for railcar manufacturing

International journal on interactive design and manufacturing, 2020-06, Vol.14 (2), p.651-666

2020

Link zum Volltext

Verfügbarkeit prüfen

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy

Cancer immunology research, 2019-07, Vol.7 (7), p.1047-1053

2019

Link zum Volltext

Verfügbarkeit prüfen

Design and simulation of a controller for an active suspension system of a rail car

Cogent engineering, 2018-01, Vol.5 (1), p.1545409

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Nature reviews. Clinical oncology, 2017-06, Vol.14 (6), p.333-334

2017

Link zum Volltext

Verfügbarkeit prüfen

Mechanical property prediction of SPS processed GNP/PLA polymer nanocomposite using artificial neural network

Cogent engineering, 2020-01, Vol.7 (1), p.1720894

2020

Link zum Volltext

Verfügbarkeit prüfen

Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study

Anaesthesia, 2021-06, Vol.76 (6), p.748-758

2021

Link zum Volltext

Verfügbarkeit prüfen

Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Nature reviews. Clinical oncology, 2017-04, Vol.14 (6), p.333-334

2017

Link zum Volltext

Verfügbarkeit prüfen

Developing a membrane-proximal CD33-targeting CAR T cell

Journal for immunotherapy of cancer, 2024-05, Vol.12 (5), p.e009013

2024

Link zum Volltext

Verfügbarkeit prüfen

Cytokine release syndrome after radiation therapy: case report and review of the literature

Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.1-1, Article 1

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytokine IL-36[gamma] improves CAR T-cell functionality and induces endogenous antitumor response

Leukemia, 2021-02, Vol.35 (2), p.506

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response

Leukemia, 2020-05, Vol.35 (2), p.506-521

2020

Link zum Volltext

Verfügbarkeit prüfen

Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity

Science immunology, 2021-09, Vol.6 (63), p.eabe6968

2021

Link zum Volltext

Verfügbarkeit prüfen

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

The Lancet (British edition), 2022-11, Vol.400 (10363), p.1607-1617

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

CD103 + cDC1 and endogenous CD8 + T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System

At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies

Development of a Prototype Test Rig for Leak Detection in Pipelines

Granulocyte‐colony stimulating factor in COVID‐19: Is it stimulating more than just the bone marrow?

The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Oncologic immunomodulatory agents in patients with cancer and COVID-19

CARs of the future

An interactive approach towards the development of an additive manufacturing technology for railcar manufacturing

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy

Design and simulation of a controller for an active suspension system of a rail car

Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Mechanical property prediction of SPS processed GNP/PLA polymer nanocomposite using artificial neural network

Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study

Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Developing a membrane-proximal CD33-targeting CAR T cell

Cytokine release syndrome after radiation therapy: case report and review of the literature

Cytokine IL-36[gamma] improves CAR T-cell functionality and induces endogenous antitumor response

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response

Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

Suchergebnisse filtern